Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Shiraz University of Medical Sciences
In this randomized, triple-blind, two-arm clinical trial, 59 adults aged 18-60 years with newly diagnosed stage 1-2 hypertension were assigned to bisoprolol 2.5 mg once daily (n=30) or a valsartan 80 mg + amlodipine 5 mg single-pill combination (n=29) for two months. Blood pressure was assessed using 24-hour ambulatory monitoring at baseline and after treatment. Statistical analysis included paired t-tests, ANOVA, and nonparametric methods, with significance set at p\<0.05.
Age
30–59
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
newly diagnosed stage 1 or stage 2 hypertension confirmed by 24-hour ambulatory blood pressure monitoring (ABPM).
You may not be if
Severe hypertension (systolic blood pressure ≥ 180 mmHg or diastolic blood pressure ≥ 110 mmHg)
Contraindications to beta-blockers
Contraindication to calcium channel blocker
Contraindication to angiotensin receptor blockers
Significant comorbidities requiring specific therapy such as diabetes or chronic heart failure, or current use of medications that could interact with the study drugs were excluded
Pregnant or breastfeeding women
Individuals with suspected secondary hypertension, and those unable to adhere to follow-up procedures